20Med Therapeutics
PrivateLast Round
Grant
Feb 2, 2023
Total Funding Raised
$850,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
20Med Therapeutics is a biotechnology company that develops RNA and DNA-based vaccines and therapeutics using a proprietary bio-responsive polymeric nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
20Med Therapeutics Comparables
Compare 20Med Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xanadu Bio | 82% | |
| Nanite, Inc. | 81% | |
| ACM Biolabs | 80% |
20Med Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2023 | ||||
| Grant | Jul 24, 2019 | ||||
| Seed | Nov 2, 2017 |
20Med Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| European Commission | Grant |
| Twente Technology Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 105% MoM.
- Oct 23, 2023
Grew 21% QoQ, from 14 to 17 employees.
20Med Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 20Med Therapeutics's valuation, stock price, and market status.
Is 20Med Therapeutics a public or private company?
20Med Therapeutics is a private company.
What is the current stock price of 20Med Therapeutics?
20Med Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is 20Med Therapeutics worth (valuation)?
Valuation information for 20Med Therapeutics is not publicly available.
Can I buy 20Med Therapeutics stock?
20Med Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was 20Med Therapeutics's last funding round?
20Med Therapeutics's most recent funding round was Grant on February 2, 2023.
Who are the main investors in 20Med Therapeutics?
Key investors in 20Med Therapeutics include CEPI, European Commission, Twente Technology Fund.
Will 20Med Therapeutics IPO soon?
No public IPO plans have been announced for 20Med Therapeutics.
How can I track 20Med Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 20Med Therapeutics's secondary market activity and sign up for updates.